Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma plus standard treatment versus standard treatment alone for severe COVID-19
PACTR202007653923168Phase 3Not yet recruiting
- Sponsor
- Kenyatta University Teaching, Referral & Research Hospital
- Start
- Aug 2020
- Countries
- 1
01
Overview
Phase 3, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Kenyatta University Teaching, Referral & Research Hospital. Primary endpoints: Safety of convalescent plasma therapy and Time to clinical improvement. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202007653923168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202007653923168.